Marilyn Morris receives AACP Volwiler Research Achievement Award

Morris is being honored for her internationally recognized work in the area of drug transporters and their role in the pharmacokinetics/pharmacodynamics (PK/PD) of drugs.

The Volwiler Research Achievement annually recognizes an individual within the ranks of pharmacy education recognized by their peers as one of the leading research workers in a given area of the pharmaceutical and clinical sciences, pharmacy practice and the social and administrative sciences, and for outstanding contributions to the respective disciplines. 

A University at Buffalo faculty member since 1985, Morris is one of the world’s preeminent scholars in the areas of drug membrane transport, pharmacokinetics and pharmacodynamics. She is widely recognized for her groundbreaking discoveries regarding the role of dietary flavonoids in drug interaction and drug resistance—research with enormous implications for patient care and drug therapy, particularly in the treatment of cancer.

Morris is the recipient of numerous prestigious awards, including the AAPS Research Achievement Award in Pharmacokinetics, Pharmacodynamics and Drug Metabolism; Francis Dudley Meyer Award for Breast Cancer Research from the Cancer Research and Prevention Foundation; the SUNY Chancellor’s Award for Excellence in Research and Creative Activity; the AAPS Innovation in Biotechnology Award; and the 2013 Alumni of Distinction Award from the University of Manitoba.

Morris is a fellow of both the American Association for the Advancement of Science and the American Association of Pharmaceutical Scientists, for which she is also past president. She is a standing member of the National Institutes of Health Xenobiotic and Nutrient Disposition and Action Study Section (XNDA) and an elected member of the executive committee of the Board of Pharmaceutical Sciences for the International Pharmaceutical Federation.

AACP will present the Volwiler Award on Monday, July 25, as part of its 2022 Annual Meeting.